Literature DB >> 20360628

Strong antioxidant activity of carane derivatives.

Tadeusz Librowski1, Andrzej Moniczewski.   

Abstract

Oxidants play a significant role in causing oxidative stress, which underlies the pathogenesis of inflammation and rheumatoid arthritis. The processes associated with inflammatory responses are complex and often involve reactive oxygen species. There are many mediators that initiate and amplify the inflammatory response such as histamine, serotonin and metabolic products of arachidonic acid (thromboxane, prostaglandins and leukotrienes). In the present study, we examined the antioxidant activity of carane derivatives--KP-23 and its optical isomers--that possess strong local anesthetic and anti-inflammatory activity. The antioxidant effects (expressed as Trolox Equivalent Antioxidants Capacity, TEAC) were observed for one of the optical isomers of carane, a derivative of propranolol--KP-23R. The relative scavenging effect (%R) of ABTS+ by KP-23S, KP-23R and standards measured at 30 min was the following, listed in decreasing order: tetracaine > KP-23S > KP-23R > procaine > lignocaine > benzocaine (99, 85, 80, 38, 21 and 20%, respectively, at a concentration of 10 mM). The IC50 values also show strong antioxidant properties of the investigated KP compounds (ranging between 11-18 mM) and tetracaine (6.2 mM) compared to other local anesthetics (129-348 mM). Moreover, monoterpene derivatives were more effective as antioxidants than propranolol diastereoisomers (280-528 mM). We found that carane derivatives, in contrast to propranolol diastereoisomers, serve as potent antioxidants by scavenging radicals.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20360628     DOI: 10.1016/s1734-1140(10)70255-3

Source DB:  PubMed          Journal:  Pharmacol Rep        ISSN: 1734-1140            Impact factor:   3.024


  1 in total

Review 1.  Procaine-The Controversial Geroprotector Candidate: New Insights Regarding Its Molecular and Cellular Effects.

Authors:  Daniela Gradinaru; Anca Ungurianu; Denisa Margina; Maria Moreno-Villanueva; Alexander Bürkle
Journal:  Oxid Med Cell Longev       Date:  2021-07-31       Impact factor: 6.543

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.